Skip to content

Clinical trials

Phase 3 Obesity trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: France Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20052
20063
20072
20081
20101
20114
20121
20131
20141
20153
20161
20171
20184
20213
20223
20232
20242
20259
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting15
Active, not recruiting8
Terminated6
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S16
Sanofi7
Eli Lilly and Company6
Assistance Publique - Hôpitaux de Paris5
Amgen4
Rhythm Pharmaceuticals, Inc.4
Centre Hospitalier Universitaire, Amiens2
Hoffmann-La Roche2
Hospices Civils de Lyon2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity57
Overweight17
Diabetes Mellitus, Type 25
Nutrition Disorders5
Diabetes Mellitus3
Obesity, Morbid3
Sleep Apnea, Obstructive3
Diabetes Mellitus, Type 12
Heart Failure2
Alstrom Syndrome1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.